Generate Biomedicines, Inc.Generate Biomedicines, Inc.
GENBHealth Care·Biotechnology
Generate Biomedicines, Inc. is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company was founded in 2018, and is headquartered in Somerville, MA.
Market cap
$1.9BNo data
Revenue
No dataNo data
Net income
No dataNo data
Free cash flow
No dataNo data
Generate Biomedicines has ample short-term liquidity from a high current ratio, but operating margin and all capital-return measures are deeply negative this quarter while asset turnover remains very low.
As of 2026-06-30Market
Listed stock
GENBPriceNasdaqLoading…Loading…1Y